Kerala AyurvedaBOM:530163 -4.55%47 Gross Margin % is 77.39% as of Mar. 2026, which is 2% above its 10-year median of 75.64. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹319.13 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 938 Drug Manufacturers companies, Kerala Ayurveda ranks better than 89.87% on this metric.
The historical rank and industry rank for Kerala Ayurveda's Gross Margin % or its related term are showing as below:
BOM:530163'
s Gross Margin % Range Over the Past 10 Years
Min: 72.37 Med: 75.64 Max: 81.14
Current: 77.73
During the past 13 years, the highestGross Margin % of Kerala Ayurveda was 81.14%. The lowest was 72.37%. And the median was 75.64%.
BOM:530163's Gross Margin % is ranked better than 89.87% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs BOM:530163: 77.73
Kerala Ayurveda had a gross margin of 77.39% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Kerala Ayurveda was 1.90% per year.
Kerala Ayurveda (BOM:530163) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Kerala Ayurveda had a gross margin of 77.39% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Kerala Ayurveda Gross Margin % Related Terms
Kerala Ayurveda Gross Margin % Historical Data
* Premium members only.
The historical data trend for Kerala Ayurveda's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530163 vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kerala Ayurveda Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Kerala Ayurveda's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Kerala Ayurveda (BOM:530163) has a Gross Margin % of 77.39% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Kerala Ayurveda and its competitors. This is near median its historical median of 75.64. Over the past decade, Kerala Ayurveda's Gross Margin % has ranged from 72.37 to 81.14. According to the industry distribution chart, Kerala Ayurveda ranks #95 out of 938 companies in the Drug Manufacturers industry, placing it in the top 10.1%.
Is Kerala Ayurveda's Gross Margin % too high?
Kerala Ayurveda's current Gross Margin % of 77.39% is near median its 10-year median of 75.64. Over the past 10 years, this metric has ranged from a low of 72.37 to a high of 81.14. The Drug Manufacturers industry median Gross Margin % is 48.54. Kerala Ayurveda's value of 77.39% is 59.4% above this industry median. Based on the distribution chart, Kerala Ayurveda ranks #95 out of 938 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #95 out of 938 companies for Gross Margin %. This places Kerala Ayurveda in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Kerala Ayurveda's value of 77.39% is 59.4% above this benchmark. Historically, Kerala Ayurveda's own Gross Margin % has ranged from 72.37 to 81.14 over the past decade. While the company's 10-year median is 75.64 vs. the industry median of 48.54, Kerala Ayurveda has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kerala Ayurveda's current Gross Margin % of 77.39% is 59.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Kerala Ayurveda and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current Gross Margin % is 77.39%, which is near median its own 10-year median of 75.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹319.13, compared to a current price of ₹162.50 — trading 49.1% below its estimated fair value. The current Gross Margin % is 77.39%, which is near median its 10-year median of 75.64 and 59.4% above the Drug Manufacturers industry median of 48.54. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Gross Margin % is 77.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?
Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued.
The current stock price of ₹162.50 is trading 49.1% below its estimated GF Value™ of ₹319.13.
GuruFocus considers Kerala Ayurveda to be Possible Value Trap.
Key valuation signals for BOM:530163:
Gross Margin %: 77.39% (near median its 10-year median of 75.64)
GF Value™: ₹319.13 vs. price of ₹162.50 (49.1% below fair value)
Industry Position: 59.4% above the Drug Manufacturers median (#95 of 938)
No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score
Get the complete analysis for BOM:530163
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530163 has been successfully added to your 
